Previous 10 | Next 10 |
home / stock / wba / wba articles
Walgreens Boots Alliance Inc. (NASDAQ: WBA) is reportedly considering appointing Tim Wentworth, a former executive at Cigna Group&nb...
Insurers, including Blue Cross and Blue Shield of Minnesota, are urging a U.S. judge to reject what they consider a "grossly in...
Consulting firm McKinsey & Company has reached a substantial settlement agreement of $230 million to resolve lawsuits filed by numero...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator,...
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several l...
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating federa...
Tech Crunch Jeff Bezos Vs. Elon Musk: Feud Takes Center Stage in Amazon's Space Contract Lawsuit An institutional investor prosecuted Ama...
Walgreens Boots Alliance Inc's (NASDAQ: WBA) CEO has agreed to step down as CEO and board member as of August 31, 2023. The company ...
News, Short Squeeze, Breakout and More Instantly...
Walgreens Boots Alliance Inc. Company Name:
WBA Stock Symbol:
NASDAQ Market:
Walgreens Boots Alliance Inc. Website:
2024-07-25 05:48:00 ET Does a rising tide really lift all boats? Not necessarily. If boats are too leaky, they can still sink no matter how much the water level rises. The S&P 500 has been in a strong bull market since October 2022. But not every stock has delivered solid gains....
2024-07-24 07:15:00 ET Walgreens Boots Alliance (NASDAQ: WBA) is a stock that's in deep trouble. Its future is uncertain, the business isn't performing well, and investors have all but abandoned it. Despite trading at a significantly reduced valuation and at prices not seen in multi...
This study aims to enhance U.S. public health preparedness through Walgreens community pharmacy network, improving access and diversity in clinical trials via a $25m award Walgreens today announced it received a project award valued up to $25 million through the Rapid Response Partnersh...